Dexcom launches over-the-counter continuous glucose sensors in the US

[August 26, 2024]  (Reuters) -Dexcom said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99.

Stelo was cleared by the U.S. health regulator in March for use by adults aged 18 and older who do not use insulin, making it the the first continuous glucose monitor available for over-the-counter sales.

Patients could buy a pack of two sensors at a one-time price of $99 or opt for a subscription to get a monthly delivery for $89, Dexcom said.

In June, rival Abbott Laboratories received the regulator's clearance for two similar devices, Libre Rio and Lingo, for adults with and without diabetes, respectively.

Abbott had said it plans to launch Lingo in the U.S. this summer.

Lingo has been available in Britain since January for 120-150 pounds ($152-$190) per month.

Dexcom's Stelo uses a wearable sensor, paired with an application on the user's smartphone or other smart device to continuously measure blood glucose levels.

The device is not for individuals with problematic hypoglycemia or low blood sugar as it is not designed to alert the user about this potentially dangerous condition.

(Reporting by Mariam Sunny in Bengaluru; Editing by Mrigank Dhaniwala and Alan Barona)

[© 2024 Thomson Reuters. All rights reserved.]This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.